The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.925
Bid: 18.40
Ask: 19.45
Change: -0.275 (-1.43%)
Spread: 1.05 (5.707%)
Open: 19.20
High: 0.00
Low: 0.00
Prev. Close: 19.20
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

3 Jan 2023 15:30

RNS Number : 5561L
BATM Advanced Communications Ld
03 January 2023
 

LEI: 213800FLQUB9J289RU66

3 January 2023

 

BATM Advanced Communications Limited

("BATM" or "the Company")

 

Grant of Options

 

Further to the Company's announcements of 24 November and 21 December 2022, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that the Company granted, on 1 January 2023 (the "Grant Date"), options over ordinary shares of 0.01 NIS each in the capital of the Company ("Ordinary Shares") to certain Directors as follows:

 

Name

Role

Number of options granted

Options exercise price

Period and conditions of vesting

Gideon Chitayat*

Chairman

1,229,369

25.49 pence

The options fully vest on the first anniversary of the Grant Date.

Moti Nagar

CEO

16,433,937

25.49 pence

 

One-third of the options will vest on each of the first, second and third anniversaries of the Grant Date.

* Dr. Chitayat's options were granted to GMBS General Management & Business Strategy Consultants Ltd., a service company through which Dr. Chitayat provides his services to the Company

 

The options were granted under the BATM Advanced Communications Ltd. Global Share Incentive Plan (2021) ("SIP (2021)"). The exercise price represents the average closing price of the Company's Ordinary Shares on the London Stock Exchange over the 30 trading days preceding the Grant Date. The options granted to Mr. Nagar have a total grant value of 2% of the value of the Company on the Grant Date, as approved by shareholders at the Company's annual general meeting of 21 December 2022. Each grantee's options are exercisable subject to that grantee remaining a service provider of the Company and for 90 days thereafter.

 

Following the above option grants, Mr. Nagar and Dr. Chitayat hold options over Ordinary Shares and Restricted Share Units ("RSUs") as detailed below:

 

Instrument

Scheme

Number

Date of grant

Exercise price (if applicable)

Date of first vesting

Conditions of vesting/exercise*

Expiry date (if applicable)

Gideon Chitayat, Chairman

Options over Ordinary Shares

SIP (2021)

1,229,369

01/01/23

25.49 pence

01/01/24

The options fully vest on the first anniversary of the grant date.

01/01/33

Moti Nagar, CEO

Options over Ordinary Shares

ESOP (2004)

906,200

05/05/15

12.69 pence

31/12/16

The options are fully vested and are exercisable.

04/05/25

SIP (2021)

16,433,937

01/01/23

25.49 pence

01/01/24

The options vest equally on the first, second and third anniversaries of the date of grant.

01/01/33

Restricted Share Units

SIP (2021)

537,109

12/04/22

N/A

12/04/25

The RSUs vest on the third anniversary of the grant date subject to total shareholder return performance over the three-year period (for details, see page 56 of BATM's Annual Report 2021). If, and to the extent that, these RSUs vest, the resulting ordinary shares will be subject to a two-year holding period, however, sufficient awards may be sold during the holding period to satisfy any tax liabilities owed. 

N/A

 

* All options and RSUs are subject to the provisions of the scheme under which they were granted and are exercisable subject to the grantee remaining a service provider of the Company and for 90 days thereafter.

 

Enquiries:

 

BATM Advanced Communications

Moti Nagar, Chief Executive Officer

+972 9866 2525

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Gideon Chitayat

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

1,229,369

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Moti Nagar

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

16,433,937

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLELEIVIIV
Date   Source Headline
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.